Home » Posts tagged with » coronavirus vaccine
Imperial College begins human trial of coronavirus vaccine candidate COVAC1

Imperial College begins human trial of coronavirus vaccine candidate COVAC1

Imperial College London said that it has dosed the first healthy volunteer with its COVAC1 coronavirus vaccine candidate, which has been developed using the new self-amplifying RNA (saRNA) technology. The university claimed that the COVID-19 vaccine candidate has gone through rigorous pre-clinical safety tests, and in animal studies, it has been demonstrated to be safe, […]

Catalent wins contract to manufacture AZD1222 COVID-19 vaccine candidate

US-based Catalent said that its subsidiary Catalent Biologics has bagged a contract to provide vial filling and packaging capacity to AstraZeneca at its manufacturing facility in Anagni, Italy, and prepare for large-scale commercial supply of AZD1222, the adenovirus vector based COVID-19 vaccine candidate of the University of Oxford. Catalent said that the agreement fast tracks […]

Continue reading …
Intranasal COVID-19 vaccine : Intravacc, WBVR and Utrecht University join forces for vaccine development

Dutch vaccine maker Intravacc has forged a partnership with Wageningen Bioveterinary Research (WBVR) and Utrecht University in the Netherlands to develop an intranasal COVID-19 vaccine. The public-private partnership will combine Intravacc’s vaccine development technology with WBVR’s viral vector technology and animal technologies and the Dutch university’s expertise in coronavirus. According to Intravacc, the potential coronavirus […]

Continue reading …
Merck to acquire coronavirus vaccine candidate developer Themis Bioscience

Merck acquisition of Themis Bioscience : Merck has signed a deal to acquire Themis Bioscience, an Austrian vaccine developer for an undisclosed price with an objective to gain access to the latter’s coronavirus vaccine candidate. Themis Bioscience by leveraging its measles virus vector platform has developed a pipeline of vaccine candidates and immune-modulatory therapies. Recently, […]

Continue reading …
Coronavirus vaccine trial results : Moderna mRNA-1273 shows early promise

Moderna said that mRNA-1273, its novel coronavirus vaccine candidate, has delivered positive interim data in a phase 1 clinical trial by eliciting neutralizing antibody titer levels in all eight initial participants across the 25 µg and 100 µg dose cohorts. The early-stage clinical trial in humans was led by the US National Institute of Allergy […]

Continue reading …
Verndari begins preclinical testing of COVID-19 vaccine candidate

Verndari, a California-based biopharma company, has started preclinical testing of a COVID-19 vaccine candidate, which will be administered using it microneedle array dermal patch VaxiPatch. The preclinical testing will be carried out in laboratories at the University of California in Davis (UC Davis). Verndari, which was established in 2015, is said to have developed the […]

Continue reading …
SARS-CoV-2 vaccine trial : Sinovac Biotec begins COVID-19 vaccine candidate human trial

SARS-CoV-2 vaccine trial : Chinese biopharma company Sinovac Biotech has started a phase 1 clinical trial for SARS-CoV-2 vaccine, its COVID-19 vaccine candidate in 144 healthy adults, aged between 18 and 59. Sinovac Biotech had recently secured approval from China’s National Medical Products Administration (NMPA) to launch the randomized, double-blinded, placebo-controlled study for the coronavirus […]

Continue reading …
Oxford University ChAdOx1 nCoV-19 vaccine trial begins in humans

Researchers at the University of Oxford in the UK have commenced the ChAdOx1 nCoV-19 vaccine trial in healthy human volunteers to test the vaccine candidate’s ability in protecting against the novel coronavirus. Nearly 1,100 people, aged between 18 and 55 are taking part in the Oxford University coronavirus vaccine trial, of which half of them […]

Continue reading …
DNA-based COVID-19 vaccine candidate being developed by University of Waterloo

DNA-based COVID-19 vaccine candidate : Researchers at the University of Waterloo in Canada are developing a DNA-based vaccine candidate which can be given via nasal route to protect from novel coronavirus. The vaccine will be formulated to work on tissues in the nasal cavity and lower respiratory tract which will enable it to replicate within […]

Continue reading …
Vaccine giants Sanofi, GSK announce COVID-19 vaccine partnership

French pharma company Sanofi has announced a COVID-19 vaccine partnership with GlaxoSmithKline (GSK) to develop an adjuvanted vaccine for the novel coranavirus, by combining their drug discovery technologies. Sanofi will provide its S-protein Covid-19 antigen based on recombinant DNA technology to the partnership. The technology is said to be used for generating an exact genetic […]

Continue reading …
Page 1 of 212